Gossamer Bio (GOSS) EBITDA (2018 - 2026)
Gossamer Bio (GOSS) posted EBITDA of -$44.61 million for Q1 2026, compared with -$36.56 million a year earlier.
Powered by 
Analysis
Gossamer Bio (GOSS) EBITDA (2018 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, EBITDA at Gossamer Bio was -$177.76 million; for FY2025, it was -$169.72 million.
- In prior years, Gossamer Bio's EBITDA was -$58 million in FY2024, -$180.83 million in FY2023, -$215.6 million in FY2022 and -$207.65 million in FY2021.
- Quarterly EBITDA has run from a low of -$55.22 million in Q3 2022 to a high of $52.71 million in Q2 2024 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$45.78 million (Q4 2025), -$48.86 million (Q3 2025) and -$38.51 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Gossamer Bio | 45.16 Mn | -428.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -44.61 Mn |
| Dec 31, 2025 | -45.78 Mn |
| Sep 30, 2025 | -48.86 Mn |
| Jun 30, 2025 | -38.51 Mn |
| Mar 31, 2025 | -36.56 Mn |
| Dec 31, 2024 | -35.78 Mn |
| Sep 30, 2024 | -33.49 Mn |
| Jun 30, 2024 | 52.71 Mn |
| Mar 31, 2024 | -41.41 Mn |
| Dec 31, 2023 | -48.43 Mn |
| Sep 30, 2023 | -39.77 Mn |
| Jun 30, 2023 | -45.46 Mn |
| Mar 31, 2023 | -47.09 Mn |
| Dec 31, 2022 | -53.66 Mn |
| Sep 30, 2022 | -55.22 Mn |
| Jun 30, 2022 | -53.07 Mn |
| Mar 31, 2022 | -53.55 Mn |
| Dec 31, 2021 | -49.47 Mn |
| Sep 30, 2021 | -53.47 Mn |
| Jun 30, 2021 | -53.52 Mn |
API Access
Gossamer Bio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();